MSKCC MSK Pulmo-Oncology Symposium 2025

+ Include: 17 videos + 16 pdfs, size: 5.8 GB

+ Target Audience: pulmonologists, hematologists, oncologists

+ Information:

Overview

Pulmo-oncology is an emerging discipline at the intersection of pulmonary medicine and oncology, playing a critical role in the clinical care of patients with cancer. The respiratory system is often impacted by direct cancer involvement and toxicities stemming from the use of anti-neoplastic agents. Pre-existing pulmonary disorders affect patient outcomes and management decisions. Effective clinical management of pulmonary complications of cancer and its therapies requires an interdisciplinary approach.

Now in its third year, this symposium brings together global experts from multiple disciplines to present the latest advances in cancer therapies and best practices in the evaluation and management of lung disease. Through state-of-the-art presentations and interdisciplinary, case-based discussions, this symposium will explore key topics related to the care of cancer patients with pulmonary comorbidities and complications arising from cancer or its treatments.

Key topics for this year’s program include:

• State-of-the-art updates in lung cancer treatment
• Navigating immune-mediated lung toxicities related to cancer therapy
• Clinical strategies for prevention, symptom management, and co-existing conditions

Complex cases will be presented throughout, with dedicated time for interactive, multidisciplinary panel discussions to encourage meaningful engagement between participants and the faculty.

Format & Audience: This symposium offers the option to attend either in person or virtually and is intended for healthcare professionals in pulmonology, hematology/oncology, and related disciplines involved in the care of cancer patients or those with a special interest in this area.

Objectives

1. Describe the role of the pulmonologist in diagnosis and management of cancer related pulmonary complications
2. Identify state of the art diagnostic and treatment strategies for management of lung cancer
3. Implement strategies for diagnosis and management of non-infectious pulmonary complications of stem cell transplant and other cancer directed therapies
4. Discuss multidisciplinary approach in complex patients
5. Implement approaches to symptom management and prevention of cancer related pulmonary complications
6. Gain insight in sleep disordered breathing in the cancer patient

The MSK Pulmo-Oncology Symposium 2025 by Memorial Sloan Kettering Cancer Center is best for pulmonologists, hematologists/oncologists, and other specialists involved in the care of cancer patients with respiratory complications. It’s ideal for:

• Understanding how cancer and anti-neoplastic therapies affect the respiratory system
• Managing patients with pre-existing pulmonary disorders and cancer-related lung toxicities
• Exploring emerging strategies in pulmo-oncology, a growing interdisciplinary field

+ Topics:

Friday, September 19, 2025

• 8:00AM – 9:00AM Beyond Fatigue: Unmasking Sleep Disordered Breathing in Patients with Cancer Miranda Tan, DO, FCCP
• 9:00AM – 9:25AM New Drugs and Combos in Lung Cancer Land Alissa Cooper, MD
• 9:25AM – 9:45AM Neoadjuvant Treatment Strategies in Resectable Neoadjuvant: The Surgical Perspective Matthew Bott, MD
• 9:45AM – 10:05AM Novel Endobronchial Approaches to Lung Cancer Therapy Rastko Rakocevic, MD, MS
• 10:05AM – 10:25AM Strategies for the Mitigation of Radiation Pneumonitis and the Role of Multidisciplinary Collaboration: A Radiation Oncologist’s Perspective Daniel Gomez, MD
• 10:25AM – 10:30AM Q&A and Discussion
• 10:30AM – 11:00AM Complex Case Presentations and Panel Discussion
• 11:15AM – 12:00PM Navigating Immune Checkpoint Inhibitor-Related Pneumonitis and Future Directions Karthik Suresh , MD
• 1:00PM – 1:25PM Antibody-Drug Conjugate (ADC) and Targeted Therapy– Induced Lung Toxicity: Clinical Insights and Rechallenge Strategies Ajay Sheshadri, MD
• 1:25PM – 1:45PM Early Non-Infectious Pulmonary Complications Following Hematopoietic Stem Cell Transplantation Andrew C Harris, MD
• 2:05PM – 2:10PM Q&A and Discussion
• 2:10PM – 2:40PM Complex Case Presentations and Panel Discussion Andrew C Harris, MD Timothy W Miller, MD Ajay Sheshadri, MD Elena Mead, MD
• 2:55PM – 3:20PM Pulmonary Rehab: A Pulmonologist’s Perspective Elizabeth Yogiaveetil, MD
• 3:20PM – 3:40PM Symptom Management Craig D Blinderman, MD, MA
• 3:40PM – 4:00PM Likes, Lies, and Lungs: Health Education in the Age of Social Media Timothy Tiutan, MD
• 4:00PM – 4:25PM Integrating Tobacco Treatment into Cancer Care and Lung Cancer Screening Jamie Ostroff, PhD
• 4:30PM – 5:00PM Complex Case Presentations and Panel Discussion Christina M. Hess, AGACNP-BC Elizabeth Yogiaveetil, MD Jamie Ostroff, PhD Timothy Tiutan, MD Craig D Blinderman, MD, MA